Co-inheritance of hemoglobin D and β-thalassemia traits in three Iranian families: Clinical relevance

Archives of Iranian Medicine

Volumn 14, Issue 1, 2011, Pages 61-63

  Basmanj, Maryam Taghavi ^a   Karimipoor, Morteza ^a   Amirian, Azam ^a   Jafarinejad, Masoumeh ^a   Katouzian, Leila ^a   Valaei, Atefeh ^a   Bayat, Fatemeh ^a   Kordafshari, Alireza ^a   Zeinali, Sirous ^a,b  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b Kawsar Genomics and Biotech Center   (Iran)

Author keywords

thalassemia; ARMS PCR; HbD; Heterozygous; Iran

Indexed keywords

BETA GLOBIN; HEMOGLOBIN A2; HEMOGLOBIN D; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

ADULT; ARTICLE; BETA THALASSEMIA; BLOOD CELL COUNT; CASE REPORT; COMORBIDITY; DNA DETERMINATION; ELECTROPHORESIS; FAMILY HISTORY; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC TRAIT; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN D DISEASE; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMAN; IRAN; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MOLECULAR DYNAMICS; MUTATIONAL ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; BETA-GLOBINS; BETA-THALASSEMIA; DNA MUTATIONAL ANALYSIS; FEMALE; HEMOGLOBINS, ABNORMAL; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INHERITANCE PATTERNS; IRAN; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 78751471605     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Weatherall DJ, Clegg JB, Gibbons R. The Thalassaemia Syndromes. Oxford London; Malden, MA: Blackwell Science; 2001. xiv 846-xiv 846.
2. Thein SL. Genetic modifiers of the beta-haemoglobinopathies. Br J Haematol. 2008; 141: 357-366.
3. Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, et al. Thalassemia in Iran: epidemiology, prevention, and management. J Pediatr Hematol Oncol. 2007; 29: 233-238.
4. Old JM. Screening and genetic diagnosis of haemoglobinopathies. Scand J Clin Lab Invest. 2007; 67: 71-86.
5. Najmabadi H, Karimi-Nejad R, Sahebjam S, Pourfarzad F, Teimourian S, Sahebjam F, et al. The beta-thalassemia mutation spectrum in the Iranian population. Hemoglobin. 2001; 25: 285-296.
6. Samavat A, Modell B. Iranian national thalassaemia screening programme. BMJ. 2004; 329: 1134-1137.
7. Atalay EO, Atalay A, Ustel E, Yildiz S, Ozturk O, Koseler A, et al. Genetic origin of Hb D-Los Angeles [beta121(GH4)Glu-->Gln, GAA-->CAA] according to the beta-globin gene cluster haplotypes. Hemoglobin. 2007; 31: 387-391.
8. Fodor FH, Eng CM. Molecular exclusion of hemoglobin SD disease by prenatal diagnosis. Prenat Diagn. 1999; 19: 58-60.
9. Perea FJ, Casas-Castaneda M, Villalobos-Arambula AR, Barajas H, Alvarez F, Camacho A, et al. Hb D-Los Angeles associated with Hb S or beta-thalassemia in four Mexican Mestizo families. Hemoglobin. 1999; 23: 231-237.
10. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16: 1215.
11. Old JM, Varawalla NY, Weatherall DJ. Rapid detection and prenatal diagnosis of beta-thalassaemia: studies in Indian and Cypriot populations in the UK. Lancet. 1990; 336: 834-837.
12. Old JM. Screening and genetic diagnosis of haemoglobin disorders. Blood Rev. 2003; 17: 43-53.
13. Ahmed M, Stuhrmann M, Bashawri L, Kuhnau W, El-Harith EH. The beta-globin genotype E121Q/W15X (cd121GAA-->CAA/cd15TGG-->TGA) underlines Hb d/beta-(0) thalassaemia marked by domination of haemoglobin D. Ann Hematol. 2001; 80: 629-633.